Single National Disability: Colombia Decree 917 of 1999 | Althox
The establishment of a standardized framework for disability assessment is crucial for ensuring equity and consistency in social security systems worldwide. In Colombia, this framework is meticulously detailed in the Single National Manual for Disability Rating, specifically Decree 917 of 1999. This decree serves as the foundational legal instrument guiding the evaluation of permanent damage caused by various health conditions, ensuring that individuals receive appropriate recognition and benefits based on their functional limitations.
This article delves into a specific segment of this comprehensive manual: Chapter VI, which focuses on the genital and urinary systems. Understanding these criteria is vital for medical professionals, legal practitioners, and individuals seeking disability benefits, as it provides a clear methodology for assessing the global deficit resulting from pathologies affecting these critical bodily functions. We will explore the general provisions and then focus on the detailed evaluation criteria for deficiencies of the upper urinary tract.
The Colombian Decree 917 of 1999 establishes a comprehensive legal framework for disability assessment, integrating medical criteria with social and legal considerations.
Table of Contents
- Introduction to Decree 917 of 1999
- Chapter VI: Genital and Urinary Systems - General Overview
- Evaluation Criteria for Upper Urinary Tract Deficiency
- Specific Considerations for Renal Function Impairment (Class IV)
- Criteria for Permanent Impairment of Urinary Lead Superior
- Conclusion and Implications of the Decree
Introduction to Decree 917 of 1999
Decree 917 of 1999, issued by the Colombian government, represents a landmark effort to standardize the assessment of occupational and common disability. This manual provides a methodological guide for determining the percentage of global deficit an individual experiences due to various health conditions, ensuring a fair and objective evaluation process. Its primary goal is to establish a uniform approach, minimizing discrepancies and promoting transparency in disability claims.
The decree is structured into several chapters, each addressing different body systems and their associated pathologies. This allows for a granular assessment that considers the specific impact of an illness or injury on an individual's functional capacity. The consistent application of these criteria is fundamental to the integrity of the social security system and the protection of workers' rights.
Chapter VI: Genital and Urinary Systems - General Overview
Chapter VI of Decree 917 is dedicated to the assessment of deficiencies within the genital and urinary systems. These systems are critical for various physiological processes, and their impairment can significantly affect an individual's quality of life and functional independence. The chapter outlines the criteria for evaluating permanent damage resulting from diseases or injuries to these systems.
The scope of analysis for this chapter is broad, encompassing the upper urinary tract, bladder, urethra, male genitalia, and female genitalia. This comprehensive approach ensures that all relevant anatomical and functional aspects are considered during the evaluation. For conditions requiring interventions like transplantation, a mandatory observation period of at least one year post-transplant is stipulated.
This observation period is crucial for accurately determining the patient's stable condition and the long-term efficacy of the treatment. It allows medical evaluators to gauge whether the individual has reached a point of maximal medical improvement, which is essential for a definitive disability rating. This scientific approach underscores the decree's commitment to evidence-based assessment.
Evaluation Criteria for Upper Urinary Tract Deficiency
The upper urinary tract, comprising the kidneys and ureters, plays a vital role in filtering waste products from the blood and producing urine. Deficiencies in this area can lead to significant health complications and functional limitations. Decree 917 provides a detailed classification system for evaluating the global deficit associated with upper urinary tract pathologies, categorized into four classes based on the severity of functional impairment.
Accurate measurement of physiological parameters, such as creatinine clearance, is fundamental for assessing upper urinary tract function.
These criteria rely on key physiological indicators such as creatinine clearance and phenolsulfonphthalein (PSP) excretion, which are standard measures of renal function. Creatinine clearance reflects the kidneys' ability to filter waste, while PSP excretion measures tubular secretion. The combination of these tests provides a comprehensive picture of renal health and efficiency.
TABLE No. 6.1: CRITERIA FOR THE ASSESSMENT OF GLOBAL GAP FOR UPPER URINARY TRACT PATHOLOGY
Class Description of criteria Global Deficit (%)
I • There is a decrease of the upper urinary tract function defined by a creatinine clearance 75 to 90 liters/24 hours (between 52-62.5 ml / min.) And has a Phenolsulfonphthalein excretion (PSP) from 15 to 20% in 15 minutes. • There are signs and symptoms of intermittent upper urinary tract dysfunction do not require continuous treatment or surveillance. 1.0-4.9
II • There is a decrease of the upper urinary tract function defined by a creatinine clearance 60 to 75 liters/24 hours (between 42-52 ml / min.) And has a PSP excretion of 10 to 15% in 15 minutes. • Although creatinine clearance is greater than 75 liters/24 hours (52 ml / min.) PSP and excretion of more than 15% in 15 minutes, the signs and symptoms of illness or upper urinary tract dysfunction requiring constant vigilance and frequent treatment. 5.0-14.9
III • displayed a decrease in the upper urinary tract function determined by creatinine clearance 40 - 60 liters/24 hours (28 to 42 ml / min.) And PSP excretion of 5 to 10% in 15 minutes. • Although creatinine clearance is from 60 to 75 liters/24 hours (42 to 52 ml / min.) and PSP excretion of 10 to 15% in 15 minutes, the symptoms and signs of disease or upper urinary tract dysfunction are incompletely controlled in surgical or medical treatment continued. 15.0-29.9
IV • There is a decrease of the upper urinary tract function determined by creatinine clearance less than 40 liters/24 hours (28 ml / min.) PSP and excretion of less than 5% in 15 minutes. • Although the creatinine clearance is 40 to 60 liters/24 hours (28 - 42 ml / min.) and the secretion of PSP is 5 - 10% in 15 minutes, the symptoms and signs of disease or upper urinary tract dysfunction persist despite surgery or constant medical. 30.0-45.0
NOTE: A person with a single kidney from any cause must be assigned 5.0% of global impairment, and has had a structural loss of an essential organ. This value must be combined with any permanent impairment (including in the remaining kidney failure) that is relevant in the present case.
The table above illustrates a progressive scale of global deficit, ranging from Class I (minimal impairment) to Class IV (severe impairment). Each class is defined by specific ranges of creatinine clearance and PSP excretion, along with the nature and intensity of symptoms and the required medical management. This structured approach allows for a consistent and objective assessment across different cases.
For instance, Class I indicates mild dysfunction with intermittent symptoms that do not necessitate continuous treatment. In contrast, Class IV signifies severe functional decline, where symptoms persist despite ongoing medical or surgical interventions. The note regarding a single kidney highlights a specific consideration, assigning a baseline 5.0% global impairment due to the structural loss of an essential organ, which is then combined with any other relevant permanent impairments.
Specific Considerations for Renal Function Impairment (Class IV)
Class IV impairment, particularly when related to chronic renal disease, warrants additional detailed criteria due to its profound impact on an individual's health and daily life. This class encompasses various etiologies, including hypertensive vascular disease of renal origin, chronic nephritis, nephrolithiasis, polycystic disease, and chronic hydronephrosis. The decree specifies several associated alterations that further define this severe category.
These alterations include the necessity of peritoneal dialysis or hemodialysis for survival, indicating irreversible renal failure. Alternatively, a renal transplant that, even after a year of evaluation, still results in serious kidney failure or significant complications, also falls under this category. This emphasizes the life-sustaining nature of these treatments and the ongoing challenges faced by patients.
The intricate nature of chronic kidney disease requires a nuanced approach to disability assessment, considering both clinical and functional impacts.
Furthermore, persistent elevation of creatinemia for four months or more, or a reduction of creatinine clearance to 20 ml/min (29 L/24 hours) or less for six months, coupled with specific secondary conditions, are critical indicators. These secondary conditions include renal osteodystrophy, manifested by severe ostealgia, fibrous osteitis, severe osteoporosis, or pathological fractures. Neuropathies, intractable prurigo, and fluid overload syndrome are also considered.
Other vital signs of severe impairment within Class IV include strong and persistent anorexia leading to significant weight loss, as per gastroenterology guidelines, and persistent anemia with a hematocrit of 30% or less. Nephrotic syndrome with important anasarca persisting for at least six months despite therapy, along with specific albumin and proteinuria levels, also qualifies. These detailed criteria ensure a thorough and accurate evaluation of severe renal dysfunction.
Criteria for Permanent Impairment of Urinary Lead Superior
Beyond the functional assessment of the upper urinary tract, Decree 917 also provides criteria for evaluating permanent impairment related to the urinary lead superior, which refers to diversions or surgical modifications of the urinary tract. These values are combined with the global deficit determined by the functional criteria mentioned previously, offering a holistic view of the individual's impairment.
The intention is to account for the additional functional and structural challenges posed by these surgical alterations, irrespective of how well they preserve renal integrity or facilitate urine elimination. This acknowledges that while a diversion might be medically necessary and functional, it still represents a permanent alteration with its own set of limitations and potential complications.
TABLE No. 6.2: CRITERIA FOR THE EVALUATION OF PERMANENT IMPAIRMENT LEADS GLOBAL FOR UPPER URINARY TRACT DEFICIENCY
DEFICIENCY LEADS GLOBAL (%)
Uretero-intestinal Referrals 5.0 - 10
Cutaneous ureterostomy without intubation 5.0 - 10
Nephrostomy or ureterostomy intubated 7.5 - 15
The table above outlines specific percentages of global deficit assigned to different types of urinary diversions. For instance, uretero-intestinal referrals and cutaneous ureterostomy without intubation are assigned a global deficit ranging from 5.0% to 10%. These procedures reroute urine flow, often impacting quality of life and requiring specific management.
Nephrostomy or intubated ureterostomy, which typically involve external drainage or more complex internal tubing, are assigned a higher range of 7.5% to 15%. This reflects the potentially greater impact on daily living and the increased medical management often associated with these interventions. These percentages are then combined with any other relevant impairments to arrive at a final global disability rating.
Conclusion and Implications of the Decree
Decree 917 of 1999, particularly Chapter VI concerning the genital and urinary systems, provides a robust and scientifically grounded methodology for assessing disability in Colombia. By detailing specific physiological parameters, clinical manifestations, and the impact of medical interventions, the decree ensures a comprehensive and equitable evaluation process. This structured approach is essential for protecting the rights of individuals with disabilities and for the efficient administration of social security benefits.
The emphasis on objective medical criteria, combined with an understanding of the long-term implications of various pathologies and surgical procedures, highlights the decree's commitment to fairness. For medical professionals, it offers a clear guide for assessment; for legal professionals, a solid basis for claims; and for individuals, a transparent pathway to recognition of their functional limitations. The continuous application and understanding of this decree remain paramount for its intended purpose.
Fuente: Contenido híbrido asistido por IAs y supervisión editorial humana.
Comentarios